Table 3. Summary of meta-analysis results for the association of rs243865 MMP-2 polymorphism with age-related macular degeneration by age.

	OR	95% CI	P (random-effects model)	I2	P (heterogeneity)
AMD patients < 65 y vs healthy subjects < 65 y (N = 3)
CC vs CT+TT	0.88	0.66–1.17	0.44	15%	0.31
AMD patients > 65 y vs healthy subjects > 65 y (N = 3)
CC vs CT+TT	0.90	0.70–1.15	0.41	0%	0.40
AMD patients > 65 y vs AMD patients < 65 y (N = 3)
CC vs CT+TT	1.19	0.78–1.81	0.43	44%	0.43

OR, odds ratio; CI, confidence interval; AMD, age-related macular degeneration; y, age in years; N, number of studies included in each meta-analysis.